Another scRNA-seq study analyzing treatment-naïve hepatoblastoma samples revealed an immune landscape marked by the aberrant accumulation of erythroblastic islands, composed of VCAM1+ macrophages and erythroid cells, which was inversely correlated with patient survival [56]. This evidence concerns the gene VCAM1 and hepatoblastoma.